| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |